Skip to main content
TipRanks
Go Ultimate75% OFF

Edenor SA (EDN) Ratios

305 Followers

Edenor SA Ratios

EDN's free cash flow for Q3 2026 was ARS-13.56B. For the 2026 fiscal year, EDN's free cash flow was decreased by ARS-100.61B and operating cash flow was ARS87.05B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.070.890.650.420.43
Quick Ratio0.910.750.600.390.40
Cash Ratio0.140.020.030.010.03
Solvency Ratio0.130.230.070.04-0.22
Operating Cash Flow Ratio0.130.230.090.030.11
Short-Term Operating Cash Flow Coverage0.412.190.6561.831.07
Net Current Asset ValueARS -2.01TARS -1.51TARS -1.55TARS -1.65TARS -237.90B
Leverage Ratios
Debt-to-Assets Ratio0.200.120.060.030.04
Debt-to-Equity Ratio0.530.320.170.100.14
Debt-to-Capital Ratio0.350.240.150.090.13
Long-Term Debt-to-Capital Ratio0.240.190.070.090.00
Financial Leverage Ratio2.612.642.673.123.23
Debt Service Coverage Ratio1.172.271.061.140.50
Interest Coverage Ratio0.820.18-0.38-0.36-0.16
Debt to Market Cap0.610.240.301.600.84
Interest Debt Per Share30953.2618508.0412154.0915891.384224.67
Net Debt to EBITDA1.200.500.330.130.08
Profitability Margins
Gross Profit Margin22.76%19.31%3.95%3.64%12.85%
EBIT Margin19.96%25.81%71.47%41.29%18.82%
EBITDA Margin27.00%33.89%83.67%50.63%27.24%
Operating Profit Margin5.00%2.23%-17.09%-15.18%-3.87%
Pretax Profit Margin9.74%9.46%25.98%-1.28%-5.03%
Net Profit Margin8.00%13.32%6.90%-3.15%-18.81%
Continuous Operations Profit Margin8.00%13.32%6.90%-3.15%-18.81%
Net Income Per EBT82.12%140.79%26.55%246.18%373.83%
EBT Per EBIT194.68%425.10%-152.09%8.44%129.88%
Return on Assets (ROA)4.13%9.00%1.47%-1.35%-27.95%
Return on Equity (ROE)10.77%23.75%3.92%-4.22%-90.20%
Return on Capital Employed (ROCE)3.45%2.07%-4.77%-11.11%-9.76%
Return on Invested Capital (ROIC)2.56%1.99%-1.21%-11.09%-9.08%
Return on Tangible Assets4.13%9.00%1.47%-1.35%-27.95%
Earnings Yield12.57%18.50%7.06%-71.20%-543.61%
Efficiency Ratios
Receivables Turnover5.777.423.304.4118.31
Payables Turnover4.433.541.581.104.65
Inventory Turnover9.6214.4816.9130.8189.54
Fixed Asset Turnover0.720.890.250.521.81
Asset Turnover0.520.680.210.431.49
Working Capital Turnover Ratio-99.76-13.70-1.33-3.14-10.08
Cash Conversion Cycle18.78-28.76-98.25-236.25-54.43
Days of Sales Outstanding63.2849.21110.6982.7919.94
Days of Inventory Outstanding37.9325.2121.5811.854.08
Days of Payables Outstanding82.43103.18230.52330.8978.44
Operating Cycle101.2174.42132.2794.6424.01
Cash Flow Ratios
Operating Cash Flow Per Share4385.985616.581632.52809.31487.78
Free Cash Flow Per Share-4029.57-2604.80-1103.4584.53151.33
Dividend Paid and CapEx Coverage Ratio0.520.680.601.121.45
Capital Expenditure Coverage Ratio0.520.680.601.121.45
Operating Cash Flow Coverage Ratio0.160.520.340.351.03
Operating Cash Flow to Sales Ratio0.060.090.100.030.03
Free Cash Flow Yield-9.27%-5.89%-7.05%5.99%27.81%
Valuation Ratios
Price-to-Earnings (P/E) Ratio6.826.3214.17-1.40-0.18
Price-to-Sales (P/S) Ratio0.640.720.980.040.03
Price-to-Book (P/B) Ratio0.861.280.560.060.17
Price-to-Free Cash Flow (P/FCF) Ratio-10.79-16.97-14.1916.713.60
Price-to-Operating Cash Flow Ratio9.917.879.591.741.12
Price-to-Earnings Growth (PEG) Ratio-0.770.11-0.030.02-0.00
Enterprise Value Multiple3.552.621.500.220.20
Enterprise Value2.87T2.39T878.94B152.14B38.30B
EV to EBITDA3.552.621.500.220.20
EV to Sales0.960.891.250.110.06
EV to Free Cash Flow-16.26-20.93-18.1941.125.78
EV to Operating Cash Flow14.949.7112.304.291.79
Tangible Book Value Per Share50750.3834420.3728154.4023831.443279.94
Shareholders’ Equity Per Share50750.3834420.3728154.4023831.443279.94
Tax and Other Ratios
Effective Tax Rate0.18-0.410.73-1.46-2.74
Revenue Per Share68309.9861385.4816014.0631888.3915731.42
Net Income Per Share5463.998176.051104.86-1005.50-2958.34
Tax Burden0.821.410.272.463.74
Interest Burden0.490.370.36-0.03-0.27
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.130.140.100.100.08
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.800.900.54-2.03-1.00

Currency in ARS